Coronary artery disease and its association with Vitamin D deficiency

Journal of Mid-Life Health

Volumn 7, Issue 2, 2016, Pages 56-59

  Aggarwal, Ramesh ^b   Akhthar, Tauseef ^a   Jain, Sachin ^b  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Atherosclerosis; coronary artery disease; Vitamin D deficiency

Indexed keywords

EID: 85018668843     PISSN: 09767800     EISSN: 09767819     Source Type: Journal    
DOI: 10.4103/0976-7800.185334     Document Type: Review

References (44)

1. Reddy KS. Cardiovascular diseases in India. World Health Stat Q 1993;46:101-7.
2. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
3. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and Vitamin D insufficiency into perspective. Br J Nutr 2005;94:483-92.
4. Clemens TL, Zhou XY, Myles M, Endres D, Lindsay R. Serum Vitamin D2 and Vitamin D3 metabolite concentrations and absorption of Vitamin D2 in elderly subjects. J Clin Endocrinol Metab 1986;63:656-60.
5. Zerwekh JE. Blood biomarkers of Vitamin D status. Am J Clin Nutr 2008;87:1087S-91S.
6. Norman AW. From Vitamin D to hormone D: Fundamentals of the Vitamin D endocrine system essential for good health. Am J Clin Nutr 2008;88:491S-9S.
7. Clemens TL, Adams JS, Nolan JM, Holick MF. Measurement of circulating Vitamin D in man. Clin Chim Acta 1982;121:301-8.
8. Wolpowitz D, Gilchrest BA. The Vitamin D questions: How much do you need and how should you get it? J Am Acad Dermatol 2006;54:301-17.
9. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949-56.
10. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, et al. IOF position statement: Vitamin D recommendations for older adults. Osteoporos Int 2010;21:1151-4.
11. Lamberg-Allardt C. Vitamin D intake, sunlight exposure and 25-hydroxyvitamin D levels in the elderly during one year. Ann Nutr Metab 1984;28:144-50.
12. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990;51:1075-81.
13. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of Vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote Vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:373-8.
14. Webb AR, Kift R, Durkin MT, O'Brien SJ, Vail A, Berry JL, et al. The role of sunlight exposure in determining the Vitamin D status of the U.K. white adult population. Br J Dermatol 2010;163:1050-5.
15. Hodgkin P, Hine PM, Kay GH, Lumb GA, Stanbury SW. Vitamin-D deficiency in Asians at home and in Britain. Lancet 1973;2:167-71.
16. Simpson R. Evidence for a specific 1,25-dihydroxyvitamin D3 receptor in rat heart. Circulation 1983;68:239.
17. Weishaar RE, Simpson RU. The involvement of the endocrine system in regulating cardiovascular function: Emphasis on Vitamin D3. Endocr Rev 1989;10:351-65.
18. Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of Vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol 1990;258 (1 Pt 1):E134-42.
19. Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the Vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007;103:521-4.
20. Loftus IM, Thompson MM. The role of matrix metalloproteinases in vascular disease. Vasc Med 2002;7:117-33.
21. Sundström J, Evans JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, et al. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: The Framingham Heart Study. Circulation 2004;109:2850-6.
22. Lorell BH, Carabello BA. Left ventricular hypertrophy: Pathogenesis, detection, and prognosis. Circulation 2000;102:470-9.
23. Uysal S, Kalayci AG, Baysal K. Cardiac functions in children with Vitamin D deficiency rickets. Pediatr Cardiol 1999;20:283-6.
24. Connor TB, Rosen BL, Blaustein MP, Applefeld MM, Doyle LA. Hypocalcemia precipitating congestive heart failure. N Engl J Med 1982;307:869-72.
25. Kawashima H. Receptor for 1,25-dihydroxyvitamin D in a vascular smooth muscle cell line derived from rat aorta. Biochem Biophys Res Commun 1987;146:1-6.
26. Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: Results from three large prospective cohort studies. Hypertension 2005;46:676-82.
27. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713-9.
28. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-dihydroxyvitamin D (3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-38.
29. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932-43.
30. Khoshdel AR, Carney SL, Nair BR, Gillies A. Better management of cardiovascular diseases by pulse wave velocity: Combining clinical practice with clinical research using evidence-based medicine. Clin Med Res 2007;5:45-52.
31. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, et al. A 16-week randomized clinical trial of 2000 international units daily Vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010;95:4584-91.
32. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, et al. 1,25(OH) 2 Vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-98.
33. Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 1992;12:671-4.
34. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 1999;340:115-26.
35. Rao M, Jaber BL, Balakrishnan VS. Inflammatory biomarkers and cardiovascular risk: Association or cause and effect? Semin Dial 2006;19:129-35.
36. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-42.
37. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of Vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.
38. Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 2005;63:493-8.
39. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006;92:39-48.
40. Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol 2010;121:425-9.
41. Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, Lebastchi AH, et al. The effects of Vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med 2012;17:394-404.
42. Donneyong MM, Hornung CA, Taylor KC, Baumgartner RN, Myers JA, Eaton CB, et al. Risk of heart failure among postmenopausal women: A secondary analysis of the randomized trial of Vitamin D plus calcium of the women's health initiative. Circ Heart Fail 2014;14:56.
43. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-14.
44. Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, et al. Effects of Vitamin D on blood pressure and cardiovascular risk factors: A randomized controlled trial. Hypertension 2015;65:1195-201.